ThePrintPod: Blockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunity

Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and Wegovy, are expiring in nearly 100 nations.